Although the synergistic combination of corticosteroids and β2 agonists may improve asthma treatment by enhancing the effect of β2-agonists, this leads to an overall increase in intracellular cAMP levels, which has been shown to reduce the presence of CD8 + cells and macrophages in individuals with COPD [46]. This evidence concerns the gene CD8A and asthma.